PREVIOUS ISSUE NEXT ISSUE
January 2017 MHE0117_CV1.jpg
Will new autoimmune drugs address cost concerns?Find out what’s in the drug pipeline for autoimmune disease.
Healthcare executive compensation changes to watchManaged care organizations may be the next target of value-based reimbursements, with bonus payments tied to the health of their company—and its members.
Get your plan members to shop around for less-expensive careSome health plans are finding success with a new program that rewards patients for seeking out cheaper care.
Top pharmacy challenges of 2017High drug prices continue to plague payers, but various contributing factors intensify the problem.
Watch list 2017: Top therapeutic areasFind out about the latest treatment and drug pipeline developments
Post-election top policy changes to watch in 2017While every new year brings change, with Donald Trump elected to become the next president, managed healthcare executives will see more changes than usual in 2017.
How Trump will change four major healthcare programs, initiativesThe ACA, Medicare, Medicaid, the Children’s Health Insurance Program, and prescription drugs are in the sights of many who will soon be running Washington.
Top 10 books health execs should read in 2017Healthcare leaders share their top book recommendations.
PREVIOUS ISSUE NEXT ISSUE